Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis

被引：0
|
作者：
Wanruchada Katchamart
Pongthorn Narongroeknawin
Ngamsiree Sukprasert
Wanwisa Chanapai
Ananya Srisomnuek
机构：
[1] Mahidol University,Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital
[2] Phramongkutklao Hospital and College of Medicine,Division of Rheumatology, Department of Medicine
[3] Mahidol University,Department of Medicine, Faculty of Medicine Siriraj Hospital
[4] Mahidol University,Division of Clinical Trials, Research Department, Faculty of Medicine Siriraj Hospital
来源：
Clinical Rheumatology | 2021年 / 40卷
关键词：
Compliance-Questionnaire-Rheumatology; Medication compliance; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1291 / 1298
页数：7
相关论文
共 50 条
  • [1] Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis
    Katchamart, Wanruchada
    Narongroeknawin, Pongthorn
    Sukprasert, Ngamsiree
    Chanapai, Wanwisa
    Srisomnuek, Ananya
    CLINICAL RHEUMATOLOGY, 2021, 40 (04) : 1291 - 1298
  • [2] Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
    Emery, Paul
    Sebba, Anthony
    Huizinga, Tom W. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (12) : 1897 - 1904
  • [3] Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis
    Suarez-Almazor, Maria E.
    Berrios-Rivera, Javier P.
    Cox, Vanessa
    Janssen, Namieta M.
    Marcus, Donald M.
    Sessoms, Sandra
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (12) : 2400 - 2407
  • [4] The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis
    Edwards, Christopher J.
    Cooper, Cyrus
    Fisher, David
    Field, Max
    Van Staa, Tjeerd P.
    Arden, Nigel K.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (07): : 1151 - 1157
  • [5] Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients
    Mittal, Niti
    Mittal, Rakesh
    Sharma, Aman
    Jose, Vinu
    Wanchu, Ajay
    Singh, Surjit
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (08) : 532 - 536
  • [6] The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Otani, Hiroshi
    Abe, Asami
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    INTERNAL MEDICINE, 2023, 62 (03) : 373 - 379
  • [7] Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis
    Di Munno, O
    Delle Sedie, A
    Rossini, A
    Adamil, S
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) : 137 - 144
  • [8] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [9] Time to Consultation and Disease-modifying Antirheumatic Drug Treatment of Patients with Rheumatoid Arthritis - Northern Alberta Perspective
    Nanji, Jalal A.
    Choi, May
    Ferrari, Robert
    Lyddell, Christopher
    Russell, Anthony S.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (04) : 707 - 711
  • [10] High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Rauscher, Veronika
    Englbrecht, Matthias
    van der Heijde, Desiree
    Schett, Georg
    Hueber, Axel J.
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (03) : 386 - 390
12345